1. Product
Overview
1.1. Market
Definition
1.2. Scope
of the Market
1.2.1. Markets
Covered
1.2.2. Years
Considered for Study
1.2.3. Key
Market Segmentations
2. Research
Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive
Summary
3.1. Overview
of the Market
3.2. Overview
of Key Market Segmentations
3.3. Overview
of Key Market Players
3.4. Overview
of Key Regions/Countries
3.5. Overview
of Market Drivers, Challenges, Trends
4. Voice
of Customer
5. Global
Small Volume Parenteral Market Outlook
5.1. Market
Size & Forecast
5.1.1. By
Value
5.2. Market
Share & Forecast
5.2.1. By
Form (Liquid, Dry)
5.2.2. By
Type (Single-dose, Multiple-dose)
5.2.3. By
Packaging (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others)
5.2.4. By
Indication (Pain Management, Cancer Care, Malnourishment, Gastrointestinal
Disorder/Diarrhea, Diabetes, Others)
5.2.5. By
Region
5.2.6. By
Company (2022)
5.3. Product
Market Map
5.3.1. By
Form
5.3.2. By
Type
5.3.3. By
Packaging
5.3.4. By
Indication
5.3.5. By
Region
6. North
America Small Volume Parenteral Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1. By
Form (Liquid, Dry)
6.2.2. By
Type (Single-dose, Multiple-dose)
6.2.3. By
Packaging (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others)
6.2.4. By
Indication (Pain Management, Cancer Care, Malnourishment, Gastrointestinal
Disorder/Diarrhea, Diabetes, Others)
6.2.5. By
Country
6.3. North
America: Country Analysis
6.3.1. United
States Small Volume Parenteral Market Outlook
6.3.1.1. Market
Size & Forecast
6.3.1.1.1. By
Value
6.3.1.2. Market
Share & Forecast
6.3.1.2.1. By
Form
6.3.1.2.2. By
Type
6.3.1.2.3. By
Packaging
6.3.1.2.4. By
Indication
6.3.2. Canada
Small Volume Parenteral Market Outlook
6.3.2.1. Market
Size & Forecast
6.3.2.1.1. By
Value
6.3.2.2. Market
Share & Forecast
6.3.2.2.1. By
Form
6.3.2.2.2. By
Type
6.3.2.2.3. By
Packaging
6.3.2.2.4. By
Indication
6.3.3. Mexico
Small Volume Parenteral Market Outlook
6.3.3.1. Market
Size & Forecast
6.3.3.1.1. By
Value
6.3.3.2. Market
Share & Forecast
6.3.3.2.1. By
Form
6.3.3.2.2. By
Type
6.3.3.2.3. By
Packaging
6.3.3.2.4. By
Indication
7. Europe
Small Volume Parenteral Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1. By
Form (Liquid, Dry)
7.2.2. By
Type (Single-dose, Multiple-dose)
7.2.3. By
Packaging (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others)
7.2.4. By
Indication (Pain Management, Cancer Care, Malnourishment, Gastrointestinal
Disorder/Diarrhea, Diabetes, Others)
7.2.5. By
Country
7.3. Europe:
Country Analysis
7.3.1. Germany
Small Volume Parenteral Market Outlook
7.3.1.1. Market
Size & Forecast
7.3.1.1.1. By
Value
7.3.1.2. Market
Share & Forecast
7.3.1.2.1. By
Form
7.3.1.2.2. By
Type
7.3.1.2.3. By
Packaging
7.3.1.2.4. By
Indication
7.3.2. United
Kingdom Small Volume Parenteral Market Outlook
7.3.2.1. Market
Size & Forecast
7.3.2.1.1. By
Value
7.3.2.2. Market
Share & Forecast
7.3.2.2.1. By
Form
7.3.2.2.2. By
Type
7.3.2.2.3. By
Packaging
7.3.2.2.4. By
Indication
7.3.3. France
Small Volume Parenteral Market Outlook
7.3.3.1. Market
Size & Forecast
7.3.3.1.1. By
Value
7.3.3.2. Market
Share & Forecast
7.3.3.2.1. By
Form
7.3.3.2.2. By
Type
7.3.3.2.3. By
Packaging
7.3.3.2.4. By
Indication
7.3.4. Italy
Small Volume Parenteral Market Outlook
7.3.4.1. Market
Size & Forecast
7.3.4.1.1. By
Value
7.3.4.2. Market
Share & Forecast
7.3.4.2.1. By
Form
7.3.4.2.2. By
Type
7.3.4.2.3. By
Packaging
7.3.4.2.4. By
Indication
7.3.5. Spain
Small Volume Parenteral Market Outlook
7.3.5.1. Market
Size & Forecast
7.3.5.1.1. By
Value
7.3.5.2. Market
Share & Forecast
7.3.5.2.1. By
Form
7.3.5.2.2. By
Type
7.3.5.2.3. By
Packaging
7.3.5.2.4. By
Indication
8. Asia-Pacific
Small Volume Parenteral Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1. By
Form (Liquid, Dry)
8.2.2. By
Type (Single-dose, Multiple-dose)
8.2.3. By
Packaging (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others)
8.2.4. By
Indication (Pain Management, Cancer Care, Malnourishment, Gastrointestinal
Disorder/Diarrhea, Diabetes, Others)
8.2.5. By
Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China
Small Volume Parenteral Market Outlook
8.3.1.1. Market
Size & Forecast
8.3.1.1.1. By
Value
8.3.1.2. Market
Share & Forecast
8.3.1.2.1. By
Form
8.3.1.2.2. By
Type
8.3.1.2.3. By
Packaging
8.3.1.2.4. By
Indication
8.3.2. Japan
Small Volume Parenteral Market Outlook
8.3.2.1. Market
Size & Forecast
8.3.2.1.1. By
Value
8.3.2.2. Market
Share & Forecast
8.3.2.2.1. By
Form
8.3.2.2.2. By
Type
8.3.2.2.3. By
Packaging
8.3.2.2.4. By
Indication
8.3.3. India
Small Volume Parenteral Market Outlook
8.3.3.1. Market
Size & Forecast
8.3.3.1.1. By
Value
8.3.3.2. Market
Share & Forecast
8.3.3.2.1. By
Form
8.3.3.2.2. By
Type
8.3.3.2.3. By
Packaging
8.3.3.2.4. By
Indication
8.3.4. Australia
Small Volume Parenteral Market Outlook
8.3.4.1. Market
Size & Forecast
8.3.4.1.1. By
Value
8.3.4.2. Market
Share & Forecast
8.3.4.2.1. By
Form
8.3.4.2.2. By
Type
8.3.4.2.3. By
Packaging
8.3.4.2.4. By
Indication
8.3.5. South
Korea Small Volume Parenteral Market Outlook
8.3.5.1. Market
Size & Forecast
8.3.5.1.1. By
Value
8.3.5.2. Market
Share & Forecast
8.3.5.2.1. By
Form
8.3.5.2.2. By
Type
8.3.5.2.3. By
Packaging
8.3.5.2.4. By
Indication
9. South
America Small Volume Parenteral Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1. By
Form (Liquid, Dry)
9.2.2. By
Type (Single-dose, Multiple-dose)
9.2.3. By
Packaging (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others)
9.2.4. By
Indication (Pain Management, Cancer Care, Malnourishment, Gastrointestinal
Disorder/Diarrhea, Diabetes, Others)
9.2.5. By
Country
9.3. South
America: Country Analysis
9.3.1. Brazil
Small Volume Parenteral Market Outlook
9.3.1.1. Market
Size & Forecast
9.3.1.1.1. By
Value
9.3.1.2. Market
Share & Forecast
9.3.1.2.1. By
Form
9.3.1.2.2. By
Type
9.3.1.2.3. By
Packaging
9.3.1.2.4. By
Indication
9.3.2. Argentina
Small Volume Parenteral Market Outlook
9.3.2.1. Market
Size & Forecast
9.3.2.1.1. By
Value
9.3.2.2. Market
Share & Forecast
9.3.2.2.1. By
Form
9.3.2.2.2. By
Type
9.3.2.2.3. By
Packaging
9.3.2.2.4. By
Indication
9.3.3. Colombia
Small Volume Parenteral Market Outlook
9.3.3.1. Market
Size & Forecast
9.3.3.1.1. By
Value
9.3.3.2. Market
Share & Forecast
9.3.3.2.1. By
Form
9.3.3.2.2. By
Type
9.3.3.2.3. By
Packaging
9.3.3.2.4. By
Indication
10. Middle
East and Africa Small Volume Parenteral Market Outlook
10.1. Market
Size & Forecast
10.1.1. By
Value
10.2. Market
Share & Forecast
10.2.1. By
Form (Liquid, Dry)
10.2.2. By
Type (Single-dose, Multiple-dose)
10.2.3. By
Packaging (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others)
10.2.4. By
Indication (Pain Management, Cancer Care, Malnourishment, Gastrointestinal
Disorder/Diarrhea, Diabetes, Others)
10.2.5. By
Country
10.3. MEA:
Country Analysis
10.3.1. South
Africa Small Volume Parenteral Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1. By
Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1. By
Form
10.3.1.2.2. By
Type
10.3.1.2.3. By
Packaging
10.3.1.2.4. By
Indication
10.3.2. Saudi
Arabia Small Volume Parenteral Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1. By
Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1. By
Form
10.3.2.2.2. By
Type
10.3.2.2.3. By
Packaging
10.3.2.2.4. By
Indication
10.3.3. UAE
Small Volume Parenteral Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1. By
Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1. By
Form
10.3.3.2.2. By
Type
10.3.3.2.3. By
Packaging
10.3.3.2.4. By
Indication
11. Market
Dynamics
11.1. Drivers
11.2. Challenges
12. Market
Trends & Developments
12.1. Recent
Development
12.2. Mergers
& Acquisitions
12.3. Product
Launches
13. Porter’s
Five Forces Analysis
13.1. Competition
in the Industry
13.2. Potential
of New Entrants
13.3. Power
of Suppliers
13.4. Power
of Customers
13.5. Threat
of Substitute Products
14. Competitive
Landscape
14.1. BML Parenteral Drugs
14.1.1. Business
Overview
14.1.2. Product
Offerings
14.1.3. Recent
Developments
14.1.4. Financials
(As Reported)
14.1.5. Key
Personnel
14.1.6. SWOT
Analysis
14.2. Rusoma Laboratories Pvt Ltd
14.3. B Braun Melsungen AG
14.4. Fresenius Kabi AG
14.5. Baxter International Inc.
14.6. Sichuan Kelun
Pharmaceutical Co Ltd
15. Strategic Recommendations
16. About Us &
Disclaimer